New CGRP-targeted migraine drugs reduce headache days with fewer side effects, offering safer, more effective treatment ...

People taking CGRP (calcitonin gene-related peptide) inhibitors had a 25% lower risk of developing glaucoma, compared to those taking other migraine meds, researchers report in the journal Neurology ...

Unexpected benefit: Monoclonal antibody CGRP inhibitors for migraine prevention were linked to a reduced risk of glaucoma in a study of 74,000 patients. Not all drugs equal: The reduced glaucoma risk ...

Lower glaucoma rates emerge in large migraine cohort study ...

The use of calcitonin gene-related peptide (CGRP) inhibitors to treat adults with migraine is linked to a 25% lower risk for ...

They've been described as "brain on fire" or "an ice pick through the head." Migraine headaches affect more than one in 10 ...

Doctors are generally open to switching medications if you explain your concerns, especially if your current treatment isn’t effective or causes side effects. Finding the right migraine medication ...

MINIMIZED WHEN POSSIBLE. WELL, IN TONIGHT’S WOMAN’S DOCTOR, IF YOU’RE A MIGRAINE SUFFERER, A NEW MEDICATION NOW IN THE MARKET IS INTENDED TO FOCUS ON THOSE EXTREME HEADACHES. MERCY MEDICAL CENTER ...

Chronic migraine can greatly affect your life, especially when the pain arrives suddenly and traditional medications don't seem to help. An alternative remedy currently being studied may offer help ...

Migraine is linked to a 30% lower risk for dementia and a 42% lower risk for Alzheimer’s disease than not having migraine, a ...

If only there were a magical pill you could pop to make migraine symptoms go away permanently—a one-and-done migraine medication that would eradicate headaches forever. But if you’re someone who’s ...